Slow-freezing versus vitrification for human ovarian tissue cryopreservation

Klocke S, Buendgen N, Koester F, Eichenlaub-Ritter U, Griesinger G (2015)
Archives of Gynecology and Obstetrics 291(2): 419-426.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ;
Abstract / Bemerkung
Ovarian tissue can be cryopreserved prior to chemotherapy using either the slow-freezing or the vitrification method; however, the data on the equality of the procedures are still conflicting. In this study, a comparison of the cryo-damage of human ovarian tissue induced by either vitrification or slow-freezing was performed. Ovarian tissue from 23 pre-menopausal patients was cryopreserved with either slow-freezing or vitrification. After thawing/warming, the tissue was histologically and immunohistochemically analyzed and cultured in vitro. During tissue culture the estradiol release was assessed. No significant difference was found in the proportion of high-quality follicles after thawing/warming in the slow-freezing and vitrification group, respectively (72.7 versus 66.7 %, p = 0.733). Estradiol secretion by the ovarian tissue was similar between groups during 18 days in vitro culture (area-under-the-curve 5,411 versus 13,102, p = 0.11). Addition of Sphingosine-1-Phosphate or Activin A to the culture medium did not alter estradiol release in both groups. The proportion of Activated Caspase-3 or 'Proliferating-Cell-Nuclear-Antigen' positive follicles at the end of the culture period was similar between slow-freezing and vitrification. Slow-freezing and vitrification result in similar morphological integrity after cryopreservation, a similar estradiol release in culture, and similar rates of follicular proliferation and apoptosis after culture.
Erscheinungsjahr
Zeitschriftentitel
Archives of Gynecology and Obstetrics
Band
291
Zeitschriftennummer
2
Seite
419-426
ISSN
PUB-ID

Zitieren

Klocke S, Buendgen N, Koester F, Eichenlaub-Ritter U, Griesinger G. Slow-freezing versus vitrification for human ovarian tissue cryopreservation. Archives of Gynecology and Obstetrics. 2015;291(2):419-426.
Klocke, S., Buendgen, N., Koester, F., Eichenlaub-Ritter, U., & Griesinger, G. (2015). Slow-freezing versus vitrification for human ovarian tissue cryopreservation. Archives of Gynecology and Obstetrics, 291(2), 419-426. doi:10.1007/s00404-014-3390-6
Klocke, S., Buendgen, N., Koester, F., Eichenlaub-Ritter, U., and Griesinger, G. (2015). Slow-freezing versus vitrification for human ovarian tissue cryopreservation. Archives of Gynecology and Obstetrics 291, 419-426.
Klocke, S., et al., 2015. Slow-freezing versus vitrification for human ovarian tissue cryopreservation. Archives of Gynecology and Obstetrics, 291(2), p 419-426.
S. Klocke, et al., “Slow-freezing versus vitrification for human ovarian tissue cryopreservation”, Archives of Gynecology and Obstetrics, vol. 291, 2015, pp. 419-426.
Klocke, S., Buendgen, N., Koester, F., Eichenlaub-Ritter, U., Griesinger, G.: Slow-freezing versus vitrification for human ovarian tissue cryopreservation. Archives of Gynecology and Obstetrics. 291, 419-426 (2015).
Klocke, Silke, Buendgen, Nana, Koester, Frank, Eichenlaub-Ritter, Ursula, and Griesinger, Georg. “Slow-freezing versus vitrification for human ovarian tissue cryopreservation”. Archives of Gynecology and Obstetrics 291.2 (2015): 419-426.

16 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

What is the net effect of introducing vitrification for cryopreservation of surplus 2PN oocytes in an IVF program?
Golakov M, Depenbusch M, Schultze-Mosgau A, Schoepper B, Hajek J, Neumann K, Griesinger G., Arch Gynecol Obstet 297(2), 2018
PMID: 29230537
Oncofertility for women with gynecologic malignancies.
Chan JL, Wang ET., Gynecol Oncol 144(3), 2017
PMID: 28012689
Cryopreservation of human ovarian tissue using the silver closed vitrification system.
Xiao Z, Zhang Y, Fan W., J Assist Reprod Genet 34(11), 2017
PMID: 28756496
The evaluation of xenotransplantation of feline ovarian tissue vitrified by needle immersed vitrification technique into male immunodeficient mice.
Demirel MA, Acar DB, Ekim B, Çelikkan FT, Alkan KK, Salar S, Erdemli EA, Özkavukçu S, Yar SS, Kanca H, Baştan A., Cell Tissue Bank (), 2017
PMID: 29039070
In Vitro Activation: A Possible New Frontier for Treatment of Primary Ovarian Insufficiency.
Cordeiro CN, Christianson MS, Selter JH, Segars JH., Reprod Sci 23(4), 2016
PMID: 26787101
Human single follicle growth in vitro from cryopreserved ovarian tissue after slow freezing or vitrification.
Wang TR, Yan J, Lu CL, Xia X, Yin TL, Zhi X, Zhu XH, Ding T, Hu WH, Guo HY, Li R, Yan LY, Qiao J., Hum Reprod 31(4), 2016
PMID: 26851603
Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival.
Henry L, Fransolet M, Labied S, Blacher S, Masereel MC, Foidart JM, Noel A, Nisolle M, Munaut C., J Ovarian Res 9(), 2016
PMID: 26868273
Successful slush nitrogen vitrification of human ovarian tissue.
Talevi R, Barbato V, Fiorentino I, Braun S, De Stefano C, Ferraro R, Sudhakaran S, Gualtieri R., Fertil Steril 105(6), 2016
PMID: 26902858
Modulation of aquaporins 3 and 9 after exposure of ovine ovarian tissue to cryoprotectants followed by in vitro culture.
Sales AD, Duarte AB, Santos RR, Alves KA, Lima LF, Rodrigues GQ, Brito IR, Lobo CH, Bruno JB, Locatelli Y, Figueiredo JR, Rodrigues AP., Cell Tissue Res 365(2), 2016
PMID: 26975215
Morphological, ultrastructural and functional imaging of frozen/thawed and vitrified/warmed human ovarian tissue retrieved from oncological patients.
Fabbri R, Vicenti R, Macciocca M, Martino NA, Dell'Aquila ME, Pasquinelli G, Morselli-Labate AM, Seracchioli R, Paradisi R., Hum Reprod 31(8), 2016
PMID: 27282911
Effect of Human Ovarian Tissue Vitrification/Warming on the Expression of Genes Related to Folliculogenesis.
Shams Mofarahe Z, Ghaffari Novin M, Jafarabadi M, Salehnia M, Noroozian M, Ghorbanmehr N., Iran Biomed J 19(4), 2015
PMID: 26175108
New advances in ovarian autotransplantation to restore fertility in cancer patients.
Salama M, Woodruff TK., Cancer Metastasis Rev 34(4), 2015
PMID: 26589603

47 References

Daten bereitgestellt von Europe PubMed Central.

Roles of activin and its signal transduction mechanisms in reproductive tissues.
Ethier JF, Findlay JK., Reproduction 121(5), 2001
PMID: 11427154
Recruitment and development of the follicle; the roles of the transforming growth factor-beta superfamily.
Findlay JK, Drummond AE, Dyson ML, Baillie AJ, Robertson DM, Ethier JF., Mol. Cell. Endocrinol. 191(1), 2002
PMID: 12044917
Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy.
Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, Haimovitz-Friedman A, Fuks Z, Xie Z, Reed JC, Schuchman EH, Kolesnick RN, Tilly JL., Nat. Med. 6(10), 2000
PMID: 11017141

A, Fertil Steril 81(Suppl 1), 2004
Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C.
Gosden RG, Baird DT, Wade JC, Webb R., Hum. Reprod. 9(4), 1994
PMID: 8046009
Restoration of ovarian function in orthotopically transplanted cryopreserved ovarian tissue: a pilot experience.
Donnez J, Squifflet J, Van Eyck AS, Demylle D, Jadoul P, Van Langendonckt A, Dolmans MM., Reprod. Biomed. Online 16(5), 2008
PMID: 18492374

A, Ann Biol Anim Biochem Biophys 19(), 1979

R, Rejuv Res 10(1), 2007
Sphingosine 1-phosphate signalling in mammalian cells.
Pyne S, Pyne NJ., Biochem. J. 349(Pt 2), 2000
PMID: 10880336
Sphingosine 1-phosphate as a therapeutic agent.
Spiegel S, Kolesnick R., Leukemia 16(9), 2002
PMID: 12200669
Intraovarian activins are required for female fertility.
Pangas SA, Jorgez CJ, Tran M, Agno J, Li X, Brown CW, Kumar TR, Matzuk MM., Mol. Endocrinol. 21(10), 2007
PMID: 17609433
The effects of FSH and activin A on follicle development in vitro.
Cossigny DA, Findlay JK, Drummond AE., Reproduction 143(2), 2012
PMID: 22106407
Activin A inhibits activation of human primordial follicles in vitro.
Ding CC, Thong KJ, Krishna A, Telfer EE., J. Assist. Reprod. Genet. 27(4), 2010
PMID: 20198416
Does sphingosine-1-phosphate have a protective effect on cyclophosphamide- and irradiation-induced ovarian damage in the rat model?
Kaya H, Desdicioglu R, Sezik M, Ulukaya E, Ozkaya O, Yilmaztepe A, Demirci M., Fertil. Steril. 89(3), 2008
PMID: 17517398
Ovarian transplantation for fertility preservation in a sheep model: can follicle loss be prevented by antiapoptotic sphingosine-1-phosphate administration?
Hancke K, Walker E, Strauch O, Gobel H, Hanjalic-Beck A, Denschlag D., Gynecol. Endocrinol. 25(12), 2009
PMID: 19906004

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 25115279
PubMed | Europe PMC

Suchen in

Google Scholar